# Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS Trials

> **NCT00151957** · PHASE3 · COMPLETED · sponsor: **Noven Therapeutics** · enrollment: 450 (actual)

## Conditions studied

- Attention Deficit Disorder With Hyperactivity

## Interventions

- **DRUG:** Methylphenidate Transdermal System

## Key facts

- **NCT ID:** NCT00151957
- **Lead sponsor:** Noven Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2017-03-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00151957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00151957, "Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS Trials". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT00151957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*